Heart and Vessels

, Volume 27, Issue 4, pp 370–376 | Cite as

Impact of hypertension on short- and long-term prognoses in patients with ST elevation myocardial infarction and without previously known diabetes

  • Chiara LazzeriEmail author
  • Serafina Valente
  • Marco Chiostri
  • Paola Attanà
  • Claudio Picariello
  • Gian Franco Gensini
Original Article


Hypertension is well established as a risk factor for the development of atherosclerosis. Data on the impact of hypertension in patients with ST elevation myocardial infarction are so far inconsistent, and are mainly related to studies performed in the thrombolytic era. We assessed the impact of hypertension over the short and long term in 560 patients with ST elevation myocardial infarction (STEMI) and without previously known diabetes, all of whom were submitted to mechanical revascularization and consecutively admitted to our Intensive Cardiac Care Unit. Hypertensive patients were older (p < 0.001), more frequently male (0.005), and they showed a reduced eGFR (p < 0.001). Smoking was more frequent in nonhypertensive patients (p < 0.001), while the incidence of three-vessel coronary artery disease was higher in hypertensive patients (p = 0.003). No difference in the in-hospital mortality rates for the two subgroups was detected. At follow-up (median 32.5 months, 25th–75th percentile 16.9–47.3 months), Kaplan–Meier survival analysis detected no differences in mortality between hypertensive and nonhypertensive patients (log rank χ 2 0.38, p = 0.538). According to our data, obtained from a large series of consecutive STEMI patients without previously known diabetes, all of whom were submitted to primary PCI, a history of hypertension does not affect mortality over either the short or the long term. Moreover, hypertensive patients showed an altered glucose response to stress, as indicated by higher admission glucose values, poorer in-hospital glucose control, and a higher incidence of acute insulin resistance (as indicated by the HOMA index). Hypertensive patients therefore appear to warrant careful metabolic management during their hospital courses.


Hypertension ST elevation myocardial infarction Nondiabetic Prognosis Acute glucose dysmetabolism 


  1. 1.
    Dzau VJ (1990) Atherosclerosis and hypertension: mechanisms and interrelationships. J Cardiovasc Pharmacol 15(suppl 5):S59–S64PubMedGoogle Scholar
  2. 2.
    Lin JF, Hsu SY, Wu S, Liau CS, Chang HC, Liu CJ, Huang HL, Ho YT, Weng SL, Ko YL (2011) Data feedback reduces door-to-balloon time in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Heart Vessels 26:25–30PubMedCrossRefGoogle Scholar
  3. 3.
    Feng Y, Shen C, Ma G, Wang J, Chen Z, Dai Q, Zhi H, Yang C, Fu Q, Shang G, Guan Y (2010) Prolonged pain to hospital time is associated with increased plasma advanced oxidation protein products and poor prognosis in patients with percutaneous coronary intervention for ST-elevation myocardial infarction. Heart Vessels 25(5):374–378PubMedCrossRefGoogle Scholar
  4. 4.
    Lewington S, Clarke R, Lewington S, Clarke R, Qizilbash N, Peto R, Collins R, Prospective Studies Collaboration (2002) Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 360:1903–1913PubMedCrossRefGoogle Scholar
  5. 5.
    Levy D, Wilson PW, Anderson KM, Castelli WP (1990) Stratifying the patient at risk from coronary disease: new insights from the Framingham Heart Study. Am Heart J 119(3 pt 2):712–717PubMedCrossRefGoogle Scholar
  6. 6.
    Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L, INTERHEART Study Investigators (2004) Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case–control study. Lancet 364:937–952PubMedCrossRefGoogle Scholar
  7. 7.
    Lee KL, Woodlief LH, Topol EJ, Weaver WD, Betriu A, Col J, Simoons M, Aylward P, Van de Werf F, Califf RM (1995) Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41,021 patients. GUSTO-I Investigators. Circulation 91:1659–1668PubMedCrossRefGoogle Scholar
  8. 8.
    Frazier CG, Shah SH, Armstrong PW, Bhapkar MV, McGuire DK, Sadowski Z, Kristinsson A, Aylward PE, Klein WW, Weaver WD, Newby LK, SYMPHONY and the Second SYMPHONY Investigators (2005) Prevalence and management of hypertension in acute coronary syndrome patients varies by sex: observations from the Sibrafiban Versus Aspirin to Yield Maximum Protection from Ischemic Heart Events Postacute Coronary Syndromes (SYMPHONY) randomized clinical trials. Am Heart J 150:1260–1267Google Scholar
  9. 9.
    Rabkin SW, Mathewson FAL, Tate RB (1977) Prognosis after acute myocardial infarction: relation to blood pressure values before infarction in a prospective cardiovascular study. Am J Cardiol 40(4):604–610PubMedCrossRefGoogle Scholar
  10. 10.
    Fresco C, Avanzini F, Bosi S, Franzosi MG, Maggioni AP, Santoro L, Bellanti G (1996) Prognostic value of a history of hypertension in 11,483 patients with acute myocardial infarction treated with thrombolysis. GISSI-2 Investigators. Gruppo Italiano per lo Studio della, Sopravvivenza nell’Infarto Miocardico. J Hypertens 14:743–750PubMedCrossRefGoogle Scholar
  11. 11.
    Aylward PE, Wilcox RG, Horgan JH, White HD, Granger CB, Califf RM, Topol EJ (1996) Relation of increased arterial blood pressure to mortality and stroke in the context of contemporary thrombolytic therapy for acute myocardial infarction. A randomized trial. GUSTO-I Investigators. Ann Intern Med 125:891–900PubMedGoogle Scholar
  12. 12.
    Majahalme SK, Smith DE, Cooper JV, Kline-Rogers E, Mehta RH, Eagle KA, Bisognano JD (2003) Comparison of patients with acute coronary syndrome with and without systemic hypertension. Am J Cardiol 92:258–263PubMedCrossRefGoogle Scholar
  13. 13.
    Jonas M, Grossman E, Boyko V, Behar S, Hod H, Reicher-Reiss H (1999) Relation to early and one year outcome after acute myocardial infarction to systemic arterial blood pressure on admission. Am J Cardiol 84:162–165PubMedCrossRefGoogle Scholar
  14. 14.
    Lazzeri C, Chiostri M, Sori A, Valente S, Gensini GF (2010) Postprocedural hyperglycemia in ST elevation myocardial infarction submitted to percutaneous coronary intervention: a prognostic indicator and a marker of metabolic derangement. J Cardiovasc Med (Hagerstown) 11(1):7–13CrossRefGoogle Scholar
  15. 15.
    Lazzeri C, Valente S, Chiostri M, Picariello C, Gensini GF (2011) Predictors of the early outcome in elderly patients with ST elevation myocardial infarction treated with primary angioplasty: a single center experience. Intern Emerg Med 6(1):41–46PubMedCrossRefGoogle Scholar
  16. 16.
    Valente S, Lazzeri C, Chiostri M, Sori A, Giglioli C, Gensini GF (2011) Prior and new onset anemia in ST-elevation myocardial infarction: a different prognostic role? Intern Emerg MedGoogle Scholar
  17. 17.
    Lazzeri C, Sori A, Chiostri M, Gensini GF, Valente S (2009) Prognostic role of insulin resistance as assessed by homeostatic model assessment index in the acute phase of myocardial infarction in nondiabetic patients submitted to percutaneous coronary intervention. Eur J Anaesthesiol 26(10):856–862PubMedCrossRefGoogle Scholar
  18. 18.
    Valente S, Lazzeri C, Chiostri M, Giglioli C, Sori A, Tigli S, Gensini GF (2009) NT-pro BNP on admission for early risk stratification in STEMI patients submitted to PCI. Relation with extension of STEMI and inflammatory markers. Int J Cardiol 132(1):84–89PubMedCrossRefGoogle Scholar
  19. 19.
    Valente S, Lazzeri C, Saletti E, Chiostri M, Gensini GF (2008) Primary percutaneous coronary intervention in comatose survivors of cardiac arrest with ST-elevation acute myocardial infarction: a single-center experience in Florence. J Cardiovasc Med (Hagerstown) 9(11):1083–1087CrossRefGoogle Scholar
  20. 20.
    European Association for Percutaneous Cardiovascular Interventions, Wijns W, Kolh P, Danchin N, Di Mario C, Falk V, Folliguet T, Garg S, Huber K, James S, Knuuti J, Lopez Sendon J, Marco J, Menicanti L, Ostojic M, Piepoli MF, Pirlet C, Pomar JL, Reifart N, Ribichini FL, Schalij MJ, Sergeant P, Serruys PW, Silber S, Sousa Uva M, Taggart D; ESC Clinical Guidelines Committee, Kolh P, Alfieri O, Dunning J, Elia S, Kappetein P, Lockowandt U, Sarris G, Vouhe P, Kearney P, von Segesser L, Agewall S, Aladashvili A, Alexopoulos D, Antunes MJ, Atalar E, Brutel de la Riviere A, Doganov A, Eha J, Fajadet J, Ferreira R, Garot J, Halcox J, Hasin Y, Janssens S, Kervinen K, Laufer G, Legrand V, Nashef SA, Neumann FJ, Niemela K, Nihoyannopoulos P, Noc M, Piek JJ, Pirk J, Rozenman Y, Sabate M, Starc R, Thielmann M, Wheatley DJ, Windecker S, Zembala M, Guidelines on myocardial revascularization (2010) The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 31(20):2501–2555PubMedCrossRefGoogle Scholar
  21. 21.
    Van de Werf F, Bax J, Betriu A, Blomstrom-Lundqvist C, Crea F, Falk V, Filippatos G, Fox K, Huber K, Kastrati A, Rosengren A, Steg PG, Tubaro M, Verheugt F, Weidinger F, Weis M, ESC Committee for Practice Guidelines (CPG) (2008) Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 29(23):2909–2945PubMedCrossRefGoogle Scholar
  22. 22.
    Lazzeri C, Valente S, Tarquini R, Chiostri M, Picariello C, Gensini GF (2010) Prognostic values of admission transaminases in ST-elevation myocardial infarction submitted to primary angioplasty. Med Sci Monit 16(12):CR567–CR574PubMedGoogle Scholar
  23. 23.
    Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J, CKD-E PI (Chronic Kidney Disease Epidemiology Collaboration) (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150(9):604–612PubMedGoogle Scholar
  24. 24.
    Deedwania P, Kosiborod M, Barrett E, Ceriello A, Isley W, Mazzone T, Raskin P, American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism (2008) Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 117(12):1610–1619PubMedCrossRefGoogle Scholar
  25. 25.
    Balkau B, Charles M, for the European Group for the Study of Insulin Resistance (EGIR) (1999) Comment on the provisional report from the WHO Consultation. Diabet Med 16:442–443PubMedCrossRefGoogle Scholar
  26. 26.
    Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and eta-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia 28:412–419PubMedCrossRefGoogle Scholar
  27. 27.
    Lazzeri C, Valente S, Chiostri M, Picariello C, Gensini GF (2010) Acute glucose dysmetabolism in the early phase of ST-elevation myocardial infarction: the age response. Diab Vasc Dis Res 7(2):131–137PubMedCrossRefGoogle Scholar
  28. 28.
    Rembek M, Goch A, Goch J (2010) The clinical course of acute ST-elevation myocardial infarction in patients with hypertension. Kardiol Pol 68:157–163PubMedGoogle Scholar
  29. 29.
    Dumaine R, Gibson CM, Murphy SA, Southard M, Ly HQ, McCabe CH, Giugliano RP, Cannon CP, Antman EM, Braunwald E (2006) Thrombolysis in Myocardial Infarction (TIMI) Study Group (2006) Association of a history of systemic hypertension with mortality, thrombotic, and bleeding complications following non-ST-segment elevation acute coronary syndrome. J Clin Hypertens 8:315–322CrossRefGoogle Scholar
  30. 30.
    Pitsavos C, Kourlaba G, Panagiotakos DB, Stefanadis C, GREECS Study Investigators (2006) Factors associated with delay in seeking health care for hospitalized patients with acute coronary syndromes: the GREECS study. Hellenic J Cardiol 47:329–336PubMedGoogle Scholar
  31. 31.
    Abrignani MG, Dominguez LJ, Biondo G, Di Girolamo A, Novo G, Barbagallo M, Braschi A, Braschi G, Novo S (2005) In-hospital complications of acute myocardial infarction in hypertensive subjects. Am J Hypertens 18(2 Pt 1):165–170PubMedCrossRefGoogle Scholar
  32. 32.
    Lazzeri C, Valente S, Chiostri M, Picariello C, Gensini GF (2011) Correlates of acute insulin resistance in the early phase of non-diabetic ST-elevation myocardial infarction. Diab Vasc Dis Res 8(1):35–42Google Scholar

Copyright information

© Springer 2011

Authors and Affiliations

  • Chiara Lazzeri
    • 1
    Email author
  • Serafina Valente
    • 1
  • Marco Chiostri
    • 1
  • Paola Attanà
    • 1
  • Claudio Picariello
    • 1
  • Gian Franco Gensini
    • 1
  1. 1.Intensive Cardiac Care Unit, Heart and Vessel DepartmentAzienda Ospedaliero-Universitaria CareggiFlorenceItaly

Personalised recommendations